What is 3SBio (1530)?
3SBio is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative biologic drugs. The company focuses on therapeutic areas such as oncology, autoimmune diseases, and endocrine disorders. It operates manufacturing facilities that comply with international quality standards and maintains a pipeline of products at various stages of development. 3SBio collaborates with global pharmaceutical firms to enhance its product offerings and extend its market reach. The company aims to provide advanced treatment options through biotechnological innovation and has established a presence in both domestic and international markets. Its operations encompass drug discovery, clinical trials, and commercialization, positioning it as a significant player in the biopharmaceutical industry.
3SBio Stock Price Today: Live Overview
The price today is shaped by the trading action, with 3SBio currently quoted at HK$22.05. The intraday range has stretched between HK$20.35 and HK$22, marking a daily percentage move of +4.7847%.
FAQ: 3SBio (1530)
What is the current price of 1530 stock?
The current price stands at HK$22.05.
Does 1530 pay dividends?
3SBio pays dividends via cash distributions (if applicable).
Does 1530 have a formal corporate presence or regional headquarters in the UAE?
3SBio operates through partners and distributors in the UAE and does not have an official regional office or subsidiary.
What is 1530 best known for?
3SBio is most famous for its biopharmaceutical products focusing on innovative therapies.
What assets are typically shown together with 1530?
Commonly shown alongside 1530: Amundi Core FTSE 100 Swap UCITS ETF, Amundi MSCI Europe UCITS ETF, Arcus Biosciences, Inc.
Latest shares articles



